The U.S. Food and Drug Administration has approved Jascayd (nerandomilast) tablets for the treatment of progressive pulmonary ...
Healio Pulmonology has compiled the top news on COPD posted in 2025.Readers were most interested in how pulmonary ...
Recommending individualized care upends a century-old model of care, but it also corresponds to what many practices are ...
Multidimensional intervention for patients with lung cancer incorporates rehabilitation, psychosocial support, nutrition guidance, health promotion, and safety surveillance.
Dear Dr. Roach: In a recent column, you noted that many patients do not properly use their inhaled asthma/chronic obstructive pulmonary disease (COPD) medications, but you didn't tell us how to ...
COPD inhaled triple therapy (BDP/FF/G) improved symptoms, lung function, adherence, and QOL in patients previously treated with inhaled dual therapy.
New ACC/AHA guidelines update management of adults with congenital heart defects but highlight the shortage of specialists ...
The "American Heart Association (AHA): Scientific Sessions 2025 Highlights" report has been added to ResearchAndMarkets.com's offering. AHA 2025 took place in New Orleans, Louisiana, between 7-10 ...
The “2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage” replaces the 2012 “Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage.” The 2023 guideline ...
Renuka Iyer, M.D., will assume the role of CMO at NCCN, focusing on advancing evidence-based cancer care and guideline ...
Common warning signs of pulmonary embolism include sudden shortness of breath, sharp chest pain that worsens with deep breathing, and coughing, sometimes with blood.
Because outcomes for patients with aortic disease are enhanced at programs with higher volumes, experienced practitioners, and extensive management capabilities, Multidisciplinary Aortic Team care is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results